The retina contains multiple cell types from the myeloid lineage that play a critical role in the immunity and homeostasis of the retinal microenvironment.[@bib1]^,^[@bib2] These cells are mainly dendritic cells and macrophages, such as microglia and hyalocytes. Microglia are innate immune cells that reside within the central nervous system, including the retina.[@bib3]^--^[@bib5] Physiologically, they react to control invading micro-organisms, regulate immune reactions and tissue repair, and release neuroprotective and anti-inflammatory factors.[@bib6]^,^[@bib7] In the human adult retina, microglia play two main functions, antigen presentation and phagocytosis.[@bib8] They provide constant surveillance of their environment and activate promptly at the onset of retinal injury, playing a crucial role during disease development and progression.[@bib4]^,^[@bib6]^,^[@bib9] Hyalocytes are considered the resident macrophages of the vitreous body.[@bib10] They were first defined by Balazs et al.,[@bib11] who described their location, lining the cortical vitreous.[@bib11]^,^[@bib12] Histologically, studies have confirmed that hyalocytes are macrophages, immune cells with the capacity to react to antibodies through specific antigenic markers.[@bib13]^,^[@bib14] Several studies have demonstrated how they react to damage or external insults.[@bib15]^,^[@bib16] They undergo changes in morphology, immunophenotype, and density in response to changes in their environment.[@bib10]^,^[@bib17] Physiologically, they help maintain the transparency of the vitreous by clearing cellular debris and secreting antiangiogenic factors that inhibit vessel growth within it.[@bib18]^,^[@bib19]

Due to their role within immunity and inflammation, both microglia and hyalocytes play important roles in retinal pathology. Several groups have demonstrated abnormal microglia accumulation and altered morphologies in retinal diseases such as glaucoma,[@bib20]^,^[@bib21] diabetic retinopathy,[@bib22]^,^[@bib23] optic neuropathy,[@bib23]^,^[@bib24] retinal detachments,[@bib25] and age-related macular degeneration.[@bib26] Similarly, studies have focused on the response of hyalocytes to pathologic conditions and have shown their role within reactions to photocoagulation,[@bib27] hyperglycemia, and VEGF secretion.[@bib10] Therefore, understanding and characterizing the different morphologic changes that these cells undergo would be helpful in better understanding of disease mechanisms, severity, and treatment effect.

Studies of retinal macrophages have predominantly been performed ex vivo or in animal models using staining and confocal imaging modalities. These studies have revealed the distribution and dynamic nature of microglia and hyalocytes under various physiologic states[@bib9]^,^[@bib28]^--^[@bib30] and changes in cell morphology and motility in response to injury.[@bib31] Recent advances in retinal imaging have enabled the visualization of retinal components at a cellular level in humans.[@bib32]^,^[@bib33] A few groups have reported the ability to visualize macrophage-like cells within the human retina with the use of commercial optical coherence tomography (OCT)[@bib34]^,^[@bib35] and adaptive optics optical coherence tomography (AO-OCT).[@bib36]^--^[@bib38] Additionally, advances in the technology of en face OCT allow the isolation of specific retinal layers, segmented according to their axial depth. This technique employs the coronal plane perspective familiar from conventional ophthalmoscopy, facilitating correlation of findings with other similarly oriented fundus imaging.[@bib35]^--^[@bib39] However, prior studies using commercial OCT devices have used only OCT B-scans or en face OCT reflectance (OCT-R) with relatively thick slabs, and therefore, it is difficult to characterize morphology and spatial distributions of macrophage-like cells.[@bib34]^,^[@bib35] AO-OCT allows in vivo high-resolution macrophage-like cell imaging, but its field of view is typically six times smaller than a commercial OCT device.[@bib36]^--^[@bib38] Another major drawback of AO-OCT systems to date has been the limited availability for clinical application due to their cost and technical complexity. In this study, we present a novel in vivo imaging approach to visualize individual macrophage-like cells in the human retina using clinical en face OCT-R images.

Methods {#sec2}
=======

Subjects {#sec2-1}
--------

This study was conducted at the New York Eye and Ear Infirmary of Mount Sinai and the Medical College of Wisconsin. All procedures adhered to the tenets of the Declaration of Helsinki and were approved by the Institution Review Board of the New York Eye and Ear Infirmary of Mount Sinai (identifier: 17-00041) and the Medical College of Wisconsin (identifier: PRO 23999). Written informed consent was obtained from all subjects. A total of 21 controls were recruited from the New York Eye and Ear infirmary of Mount Sinai and the Medical College of Wisconsin. Three patients with different retinal pathologies were also recruited from the New York Eye and Ear infirmary of Mount Sinai.

Subjects inclusion criteria required a natural lens, clear media, and good fixation. Subjects were excluded for any evidence of active anterior chamber inflammation, pseudophakia, cataract of any type ≥ grade 3 according to the Lens Opacity Classification System III, other significant opacities, nystagmus, and inability to fixate. Controls were also excluded if they had any systemic vascular diseases such as hypertension, diabetes, and sickle cell disease. All controls were devoid of any retinal or optic nerve pathology on fundus photographs and OCT scans of the macula and optic nerve head (ONH). Only one eye from each subjects was included for imaging and data analysis.

En Face OCT-R and OCT Angiography Image Acquisition {#sec2-2}
---------------------------------------------------

Each control was imaged at three sessions using a commercial spectral domain OCT System with a scan rate of 70,000 A-scans per second, scan beam wavelength centered at 840 nm, and bandwidth of 45 nm (Avanti RTVue-XR; Optovue, Fremont, CA, USA). There were 304 A-scans per B-scan and a total of 608 B-scans per volumetric raster scan with two sequential B-scans taken at each location. Each OCT-R and OCT angiography (OCT-A) image was composed of a merged X-fast and Y-fast volumetric raster scan. Spacing between B-scans was 10 µm and 15 µm in a 3-mm × 3-mm and 4.5-mm × 4.5-mm raster scan, respectively. The device has an axial and lateral optical resolution of 5 µm and 10 µm, respectively. In the first imaging session, three sets of 10 scans were obtained. The first set consisted of 10 sequential 3-mm × 3-mm scans centered at 9 degrees temporal from the fovea, the second set consisted of 10 sequential 3-mm × 3-mm scans centered at the fovea, and the third set consisted of 10 sequential 4.5-mm × 4.5-mm scans centered at the ONH. The second imaging session was performed 2 to 6 hours after the first session. The third imaging session was performed 3 days later. Only 10 sequential 3-mm × 3-mm scans centered at 9 degrees temporal from the fovea were obtained in the second and third imaging sessions. In controls, intervisit repeatability was evaluated by comparing the temporal retina scans collected at three imaging sessions. In brief, each control received a total of 50 scans with 30 scans at the temporal retina, 10 scans at the macula, and 10 scans at the ONH. Patients with retinal pathologies were only imaged once with 10 sequential 3-mm × 3-mm scans at the temporal retina. While the total chair time was approximately 15 minutes for each set of 10 scans, actual scan times were considerably shorter. Following image acquisition, OCT-R and corresponding OCT-A images were generated using the Optovue AngioAnalytics software (version 2017.1.0) and the XR-Avanti Exporting Tool (version 2019.1.28) (Optovue). While OCT-R images were generated using the mean projection of the reflectance signal, OCT-A images were generated using the split-spectrum amplitude decorrelation angiography algorithm.[@bib40] For the visualization of macrophage-like cells on the retinal surface, a 3-µm OCT-R slab located above the inner limiting membrane (ILM) was used for further image processing and analysis ([Fig. 1](#fig1){ref-type="fig"}). Specifically, a 3-µm OCT-R slab located between the ILM and 3 µm above the ILM was extracted for the macular and temporal regions, and a 3-µm OCT-R slab located between 3 and 6 µm above the ILM was extracted for the ONH region. This 3-µm OCT-R slab above the ILM was studied due to the high likelihood of capturing the macrophage-like cells at this level since better structural contrast on the OCT-R image could be achieved by excluding the strong background signal from the highly reflective retinal nerve fiber layer (RNFL) underneath.

![The 3-mm × 3-mm en face OCT-R imaging of the temporal retina in a healthy control using a clinical OCT device. (**A**) The 3-µm OCT-R slab located above the ILM, showing regular spatial separation of macrophage-like cells. Fovea is located to the *left* of the image. (**B1,** **B2**) Horizontal OCT and OCT-A B-scan at the position indicated by the *yellow horizontal line* in **A**. (**C1,** **C2**) Vertical OCT and OCT-A B-scan at the position indicated by the *blue vertical line* in **A**. (**D**) Magnified OCT B-scan (rotated horizontally) at the region indicated by the *white box* in **C1**. The axial depth of the 3-µm OCT-R slab in **A** is indicated by the *parallel red lines*. *Red arrows* indicate individual cells on the ILM surface. All B-scans were flattened at the ILM for better visualization of the macrophage-like cells on the ILM surface.](iovs-61-6-48-f001){#fig1}

Image Registration and Averaging {#sec2-3}
--------------------------------

Image registration and averaging were performed on the OCT-R and OCT-A images to increase the signal-to-noise ratio and enhance visualization of macrophage-like cells and capillary networks. Studies previously published by our laboratory have demonstrated the value of image averaging in removal of motion artifacts and improving structural contrast on OCT-R images and continuity of vascular outlines on OCT-A images.[@bib41]^,^[@bib42]

For each set of 10 scans, full vascular OCT-A slabs located between the ILM and 9 µm below the outer plexiform layer were used as the primary data set for registration using the Register Virtual Stack Slices plug-in on ImageJ[@bib43] (ImageJ, US National Institutes of Health, Bethesda, MD, USA). The transformation matrix from this set of full vascular OCT-A images was then applied to the corresponding 3-µm OCT-R slabs using the Transform Virtual Stack Slices plug-in on ImageJ. For better understanding of the spatial relationship between the macrophage-like cells, retinal vascular network, and retinal nerve fiber bundles, respective OCT-R and OCT-A slabs located between the ILM and 27 µm below the ILM from the same set of 10 scans were also registered ([Fig. 2](#fig2){ref-type="fig"}). Color overlay of the macrophage-like cell layer, retinal vascular network, and RNFL was performed using Adobe Photoshop CS6 (Adobe Systems, Inc., San Jose, CA, USA) ([Figs. 2](#fig2){ref-type="fig"}D, [2](#fig2){ref-type="fig"}E). In brief, each layer was first coded in a designated color and then contrast stretched using the levels tool. Specifically, the macrophage-like cell layer was coded in green, the retinal vascular network was coded in red, and the RNFL was coded in blue. After contrast stretching, the macrophage-like cell layer was merged with either the retinal vascular network or the RNFL for better visualization of the spatial relationships among structures.

![Simultaneous imaging of (**A**) superficial retinal vascular network, (**B**) macrophage-like cells, and (**C**) RNFL at the temporal retina in a healthy control. (**D,** **E**) Overlay of superficial retinal vascular network (*red*), macrophage-like cells (*green*), and retinal nerve fiber bundles (*blue*) shows the spatial relationships among structures. Fovea is located to the *left* of all images.](iovs-61-6-48-f002){#fig2}

Macrophage-Like Cell Density and Nearest Neighbor Distance Analysis {#sec2-4}
-------------------------------------------------------------------

Macrophage-like cell density and nearest neighbor distance (NND) were measured on the averaged 3-µm OCT-R slab at the temporal retina and the ONH. No measurement was performed on the macula region due to the poor visibility of cell structures. One trained expert manually marked the center of the macrophage-like cells on a 500-µm × 500-µm region of interest (ROI) near the center of the temporal retina and at the supero- and inferotemporal of the ONH on the averaged 3-µm OCT-R images obtained at each imaging session. In the temporal retina, measurements were performed on the same ROI in all three imaging sessions. Cell density and NND were then computed within each ROI. Axial length was obtained using an IOL Master (Carl Zeiss Meditec, Dublin, CA, USA) for ocular magnification correction of each image.[@bib44] A second independent grader performed cell density and NND measurements on the baseline scans for intergrader agreement or reproducibility analysis.

Statistical Analysis {#sec2-5}
--------------------

All statistical analyses were performed using SPSS 24.0 (IBM Corporation, Chicago, IL, USA). Differences between the temporal retina (mean of three imaging sessions) and ONH (mean of superotemporal and inferotemporal) measurements were compared using the Wilcoxon signed-rank test. Intervisit repeatability was assessed using interclass correlation coefficients (ICCs) with 95% confidence intervals (CIs) and within-subject standard deviation (S~w~),[@bib45] using macrophage-like cell density and NND measurements at the temporal retina over all three imaging sessions. Intergrader reproducibility on the macrophage cell density and NND was assessed on the baseline temporal retina imaging session using ICCs with 95% CIs and the Bland-Altman plot.

Results {#sec3}
=======

Subjects {#sec3-1}
--------

Of the 21 controls who were recruited, 3 were excluded due to inability to complete all three imaging sessions. In total, 18 controls were included for image analysis (age range: 22--36 years; mean age: 27.9 ± 4.0 years; male: 9; female: 9). Three patients with different pathologies---proliferative diabetic retinopathy (PDR), central retinal vein occlusion (CRVO), and open angle glaucoma (OAG)---were also recruited for demonstration of macrophage-like cell imaging in patients and qualitative comparison with the controls.

Macrophage-Like Cell Morphology and Translocation {#sec3-2}
-------------------------------------------------

In controls, macrophage-like cells were clearly visible on the averaged 3-µm OCT-R slab of both the temporal retina and the ONH images; however, cell structures were not resolvable at the macula ([Fig. 3](#fig3){ref-type="fig"}). Cellular morphology appeared more slender with spindle- or star-like configuration at the temporal retina as compared to the ONH. Upon close examination of the images, ramified macrophage-like cells with two or more protrusions extending in any direction were observed at the temporal retina. Regular spatial separation of the cell structures was also observed at the temporal retina and ONH. These cell structures appeared to be evenly distributed without lateral overlapping and colocalized with larger blood vessels appearing on the retinal nerve fiber layer (RNFL) surface ([Fig. 3](#fig3){ref-type="fig"}). Cell translocation was observed within the same day and 3 days later ([Figs. 4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}).

![Spatial distribution of macrophage-like cells and the corresponding superficial retinal vascular network across the retina in a single example of a healthy control. (**A**) Montage of 3-µm OCT-R slabs located above the ILM surface. (**B**) Montage of 27-µm OCT-A slabs located below the ILM surface. *Asterisks* indicate the center of the foveal avascular zone.](iovs-61-6-48-f003){#fig3}

![In vivo imaging of macrophage-like cells over time in a healthy control. *Left column*: 3-µm OCT-R slabs located above the ILM surface. *Middle column*: 27-µm OCT-R slabs located below the ILM surface, showing the retinal nerve fiber bundles at the temporal raphe. *Right column*: 27-µm OCT-A slabs located below the ILM surface. Fovea is to the *left* of all images.](iovs-61-6-48-f004){#fig4}

![In vivo imaging of macrophage-like cells over time in a healthy control (same subject as shown in [Fig. 4](#fig4){ref-type="fig"}). *Left column*: 3-µm OCT-R slabs located above the ILM surface at the temporal retina. *Middle column*: OCT-R (baseline in *green*, 6 hours follow-up in *red*, and 3 days follow-up in *blue*) and OCT-A overlaid. *Right column*: Merged OCT-R and OCT-A images from two imaging sessions. Cell structures are in different locations at 6 hours and 3 days later, suggesting cell translocation over time. Fovea is located to the *left* of all images.](iovs-61-6-48-f005){#fig5}

Nonuniform spatial distribution and altered morphology of the macrophage-like cells were identified in patients with retinopathies ([Fig. 6](#fig6){ref-type="fig"}). Their morphology appeared relatively larger and more plump with fewer protrusions. Comparisons of macrophage-like cells in healthy controls and patients are shown in [Figure 7](#fig7){ref-type="fig"}. In eyes with PDR and CRVO, clusters of cell structures with less slender cell appearance were observed in the temporal retina as compared to controls ([Fig. 6](#fig6){ref-type="fig"}, red arrows). These cell structures also appeared to colocalize with the surface of the larger blood vessels ([Fig. 6](#fig6){ref-type="fig"}, yellow arrows). In the eye with OAG, diffuse macrophage-like cells and less slender cell appearances were associated with areas of severe RNFL thinning.

![In vivo imaging of macrophage-like cells in patients with retinal pathologies. *Left column* shows 3-µm OCT-R slabs located above the ILM in patients with PDR (*top row*), CRVO (*middle row*), and OAG (*bottom row*) showed nonuniform distribution and altered morphology of the macrophage-like cells. Corresponding OCT-R and OCT-A of the underlying retinal nerve fiber bundles along the temporal raphe and superficial retinal vascular network are shown in the *middle* and *right columns*. *Red arrows* indicate clusters of cells. *Yellow arrows* indicate colocalization of cell structures and larger blood vessels. Fovea is to the *left* of all images.](iovs-61-6-48-f006){#fig6}

![Comparisons of macrophage-like cells in six healthy controls and three patients with different retinal pathologies obtained at the temporal retina. Two ROIs with relatively higher and lower cell densities were shown in each patient. Macrophage-like cells in controls appear more slender with spindle- or star-like configuration. In patients, the cells look relatively larger and plumper with fewer protrusions. Each panel is 300 µm × 300 µm in size.](iovs-61-6-48-f007){#fig7}

Macrophage-Like Cell Density and Nearest Neighbor Distance Analysis {#sec3-3}
-------------------------------------------------------------------

There was considerable variation in macrophage-like cell density and NND across controls. Boxplots of the cell density and NND measured on the temporal retina and ONH are shown in [Figure 8](#fig8){ref-type="fig"}. Mean ± SD cell densities measured at the temporal and ONH were 78 ± 23 cells/mm^2^ (range: 44--156 cells/mm^2^) and 57 ± 16 cells/mm^2^ (range: 20--92 cells/mm^2^), respectively. Similarly, mean ± SD NNDs measured at the temporal and ONH were 74.3 ± 13.3 µm (range: 44.3--108.8 µm) and 93.3 ± 20.0 µm (range: 62.1--164.2 µm), respectively.

![Boxplots of the (**A**) macrophage-like cell density and (**B**) NND measured on the temporal retina at three imaging sessions and ONH (superotemporal \[ST\] and inferotemporal \[IT\]). Mean macrophage-like cell density was significantly higher in the temporal retina than that of the ONH (*P* = 0.001, Wilcoxon signed-rank test). However, the mean NND was significantly lower in the temporal retina than that of the ONH (*P* \< 0.001, Wilcoxon signed-rank test).](iovs-61-6-48-f008){#fig8}

The mean cell density was significantly higher in the temporal retina than near the ONH (*P* = 0.001, Wilcoxon signed-rank test). Likewise, the mean NND was significantly lower in the temporal retina than near the ONH (*P* \< 0.001, Wilcoxon signed-rank test; [Fig. 8](#fig8){ref-type="fig"}).

For intervisit repeatability, cell density measured at the temporal retina was moderately correlated between the three sessions, with an ICC of 0.77 (95% CI, 0.49--0.90) for the first versus second session and 0.65 (95% CI, 0.28--0.85) for the first versus third session. In contrast, measurement of NND showed low agreement between the three sessions, with an ICC of 0.47 (95% CI, −0.47 to 0.76) for the first versus second session and 0.09 (95% CI, −0.37 to 0.52) for the first versus third session. The within-subject SD (defined as 2.77 times the within-subject standard deviation S~w~) was 12.35 cells/mm^2^ and 10.59 µm for cell density and NND, respectively.

For intergrader reproducibility, there was excellent correlation on cell density and NND measurements obtained at the temporal retina by both graders on baseline scans, with an ICC of 0.98 (95% CI, 0.96--0.99) for cell density measurement and 0.97 (95% CI, 0.92--0.99) for NND measurement. Bland-Altman plots showed no significant bias between graders (mean ± SD difference between graders was −1.11 ± 4.50 cells/mm^2^ and −1.24 ± 3.30 µm for cell density and NND, respectively).

Discussion {#sec4}
==========

In this study, we present a novel image-processing approach using a clinical OCT device to visualize in vivo human macrophage-like cells located on the ILM surface ([Fig. 1](#fig1){ref-type="fig"}). Our findings showed regular spatial separation and morphology of these cells with cell translocation over time in healthy controls ([Fig. 5](#fig5){ref-type="fig"}). Their spatial distribution and morphology characteristics suggest the nature of macrophage-like cells such as microglia or hyalocytes.

In vivo visualization of macrophage-like cells within the retina has been reported previously. Liu et al.[@bib36] were the first group to image star-shaped cells on the surface of the ILM in living human retina using AO-OCT and hypothesized they were microglia or astrocytes. Following this, two groups imaged the retinal star-shaped cells, one of them on mice using adaptive optics - scanning light ophthalmoscopy (AO-SLO) fluorescence[@bib46] and the other with AO-OCT on humans,[@bib37] and labeled them as microglia. Histologically, microglia within the healthy retina remain in a dormant state while they actively survey their environment.[@bib47]^--^[@bib50] In their resting state, they have a quiescent phenotype, characterized by small somata and ramified filodopia-like processes.[@bib23]^,^[@bib51] The description of dormant microglia matches with the star-shaped cells described by both studies as well as the appearance of the cells revealed within our own images. Additionally, time-lapse confocal microscopy has demonstrated their dynamic behavior as evidenced by the continuous movement of their processes.[@bib9] They appear to be in constant motion, extending and retracting with the purpose of surveying their environment.[@bib51] The motility of their processes is supported by our own observations of shifts in location and orientation of these macrophage-like cells between images at different time points of the same control subject ([Fig. 5](#fig5){ref-type="fig"}). This finding is also consistent with several animal studies that reported microglial motility in the brain and retina.[@bib52]^,^[@bib53] This cell motility over time could therefore explain the relatively low intervisit repeatability of NND measurements in the current study. Other studies hypothesized that hyperreflective spots seen on a commercial OCT B-scan could be activated microglia, and they were able to find these spots in some of their controls on the ILM.[@bib34]^,^[@bib54] Two studies that specifically harvested human ILM using surgical procedures demonstrated the presence of cells of glial origin in the surgical specimens using histologic staining.[@bib55]^,^[@bib56] These studies, conducted on the maculae of diabetics, suggested that the cells were of glial origin, specifically microglia, within this retinal layer. Similarly, when compared to histologic studies, our own findings, which showed wide variation between individuals in cellular density, appeared to closely correspond to data previously reported.[@bib30] Additionally, our NND calculations were similar to results reported on mice.[@bib9]

In healthy adults, retinal microglia are mainly found within the inner retinal layers, including the nerve fiber layer, the ganglion cell layer, and the inner and outer plexiform layers.[@bib57]^--^[@bib59] In contrast to histologic studies that have been able to visualize these cells at levels below the ILM, we have only able to visualize these star-shaped cells above the ILM surface ([Fig. 1](#fig1){ref-type="fig"}D). This may have been due to the reduced contrast between the macrophage-like cells and the neighboring tissue within the retina on our OCT-R images. The inability to visualize these macrophage-like cells within the retina may also suggest the possibility of imaging hyalocytes instead of microglia. Hyalocytes are cells that reside in the vitreous cavity. They localize to the peripheral or cortical regions of the vitreous body, at the base and the posterior hyaloid, lining the inner surface of the retina, close to the ILM.[@bib60]^--^[@bib62] Hyalocytes have been described by light microscopy as being spindle-shaped, round, or star-shaped cells. Their location and morphology described in previous studies are consistent with the macrophage-like cells we have visualized. Also consistent with our findings, a recent in vivo AO-OCT imaging study showed that ramified macrophage-like cells with cellular motion located right above the ILM surface could be indicative of hyalocytes instead of microglia due to the inability to visualize these cell structures within the human retina.[@bib38] Additionally, several studies have reported hyalocytes as exhibiting amoeboid movement and motion of their processes, which is consistent with our findings of cell translocation between imaging sessions.[@bib63]^,^[@bib64] The role of hyalocytes within vitreoretinal disease has being recently studied, specifically within epiretinal membranes. Kohno et al.[@bib65] found that most of the cells located at the center of this membrane are hyalocytes. This is also consistent with the hypothesis that the cells we have imaged are of hyalocyte lineage. Additionally, histologic studies of guinea pig[@bib14] and mice eyes[@bib10] have reported hyalocytes on the surface of the ILM in densities similar to those we observed.

Both microglia and hyalocytes undergo changes in their morphology and spatial distribution in reaction to intrusions into their environment. Microglia\'s processes shorten, and their cell bodies change into an amoeboid state with larger cell bodies, as they proliferate and alter their distribution and cluster around lesions.[@bib3]^,^[@bib8]^,^[@bib66] Hyalocytes have also been described as having a bloated appearance in the diseased retina.

In the present study, nonuniform distribution and altered morphology of the macrophage-like cell were seen in eyes of patients with retinopathies ([Fig. 6](#fig6){ref-type="fig"}). These cells, which appeared to adhere or aggregate on the surface of both larger and smaller blood vessels, showed reduced cell density in the neighboring area. Unlike healthy controls, this appearance of cell adherence on the superficial large blood vessels and deeper small blood vessels may have been due to RNFL thinning in eyes with retinopathies. RNFL thinning exposes deeper small blood vessels close to the ILM surface, giving the false impression that these cells are located at different axial locations within the retina. In addition, clustered cell structures with plumper appearance were found on the ILM surface in patients, suggesting active translocation of these cells in response to retinal injury. These changes in morphology and behavior within the damaged retina further support our hypothesis that these are macrophage-like cells, either microglia or hyalocytes.[@bib6]^,^[@bib26]^,^[@bib67]^,^[@bib68] Further investigation of their behavior in relation to retinal injuries and/or other retinal neurons may provide more insight into their identity.

Our study is limited in several aspects. First, we were unable to visualize these macrophage-like cells on the ILM surface of the macula. This may have been due to the needle-like morphology described for foveal microglia,[@bib69] which is beyond the resolution limit of the OCT device used in the current study. Second, due to the noninvasive nature of the imaging approach, we are unable to confirm the exact origin and lineage cells using cell surface markers; we can only hypothesize their identity based upon features described in the literature. Third, even though changes in cell location were observed at different imaging sessions, visualization of continuous cell motility was not possible, and therefore, cells were not trackable across imaging sessions. Fourth, the current study involves a limited sample size and age range, which reduces our ability to apply the results to older populations. Previous literature has pointed to differences in microglial density across age groups.[@bib30] Furthermore, the technique requires acquisition of 10 sequential scans to achieve an adequate signal-to-noise ratio, which is not clinically practical, especially for many patients who have difficulty with fixation. Finally, the current method of manual cell identification on amoeboid structures is both time-consuming and fraught with inaccuracy. Perhaps future advances in clinical OCT technology will achieve real-time multiple volume averaging and high-resolution cellular imaging necessary for robust automated cell identification and morphologic analyses.

Conclusion {#sec5}
==========

In summary, we have demonstrated that clinical OCT can be used to image individual macrophage-like cells. These may have the potential to be used as biomarkers of activity of inflammation or other activated states within the retina. Future studies will help with further characterization of these cells for clinical application and better understanding of how their morphology and spatial distribution correlate with various retinal diseases.
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